Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elevance HealthELV +0.88%90 EV-to-OCF is 14.42 as of Aug. 21, 2026, which is 7% below its 10-year median of 15.44. GuruFocus rates ELV with a GF Score™ of 90/100 and a GF Value™ of $483.93 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks worse than 61.11% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Elevance Health's Enterprise Value is $107,647 Mil.
Elevance Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $7,464 Mil. Therefore, Elevance Health's EV-to-OCF for today is 14.42.
The historical rank and industry rank for Elevance Health's EV-to-OCF or its related term are showing as below:
ELV'
s EV-to-OCF Range Over the Past 10 Years
Min: 7.31 Med: 15.44 Max: 73.18
Current: 14.42
During the past 13 years, the highest EV-to-OCF of Elevance Health was 73.18. The lowest was 7.31. And the median was 15.44.
ELV's EV-to-OCF is ranked worse than 61.11% of 18
companies
in the Healthcare Plans industry
Industry Median: 11.79
vs ELV: 14.42
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elevance Health's PE Ratio (TTM) for today is calculated as:
Elevance Health's share price for today is $399.76.
Elevance Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.500.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Elevance Health EV-to-OCF Related Terms
Elevance Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Elevance Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Elevance Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health EV-to-OCF vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Elevance Health's EV-to-OCF falls into.
Elevance Health's current Enterprise Value is $107,647 Mil.
Elevance Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,464 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (ELV) has a EV-to-OCF of 14.42 as of Aug. 21, 2026. This is near median its historical median of 15.44. Over the past decade, Elevance Health's EV-to-OCF has ranged from 7.31 to 73.18. According to the industry distribution chart, Elevance Health ranks #11 out of 18 companies in the Healthcare Plans industry, placing it in the top 61.1%.
Is Elevance Health's EV-to-OCF too high?
Elevance Health's current EV-to-OCF of 14.42 is near median its 10-year median of 15.44. Over the past 10 years, this metric has ranged from a low of 7.31 to a high of 73.18. The Healthcare Plans industry median EV-to-OCF is 11.79. Elevance Health's value of 14.42 is 22.3% above this industry median. Based on the distribution chart, Elevance Health ranks #11 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Elevance Health has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's EV-to-OCF compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #11 out of 18 companies for EV-to-OCF. This places Elevance Health in the lower half of its industry. The industry median EV-to-OCF is 11.79. Elevance Health's value of 14.42 is 22.3% above this benchmark. Historically, Elevance Health's own EV-to-OCF has ranged from 7.31 to 73.18 over the past decade. While the company's 10-year median is 15.44 vs. the industry median of 11.79, Elevance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Plans company?
The median EV-to-OCF among Healthcare Plans companies is 11.79, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current EV-to-OCF of 14.42 is 22.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median EV-to-OCF is 11.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current EV-to-OCF is 14.42, which is near median its own 10-year median of 15.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is $483.93, compared to a current price of $399.76 — trading 17.4% below its estimated fair value. The current EV-to-OCF is 14.42, which is near median its 10-year median of 15.44 and 22.3% above the Healthcare Plans industry median of 11.79. Elevance Health's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Elevance Health (ELV), the current EV-to-OCF is 14.42 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of $399.76 is trading 17.4% below its estimated GF Value™ of $483.93.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for ELV:
EV-to-OCF: 14.42 (near median its 10-year median of 15.44)
GF Value™: $483.93 vs. price of $399.76 (17.4% below fair value)
Industry Position: 22.3% above the Healthcare Plans median (#11 of 18)
No single metric tells the full story. See the ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
90GF Score
Get the complete analysis for ELV
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELV has been successfully added to your 
